🇺🇸 FDA
Patent

US 10752699

Anti-APOBEC3 antibodies and methods of making and using

granted A61PA61P37/06

Quick answer

US patent 10752699 (Anti-APOBEC3 antibodies and methods of making and using) held by Regents of the University of Minnesota expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P37/06